Axio BioPharma
Madison
About Axio BioPharma
Axio BioPharma is a Contract Development and Manufacturing Organization (CDMO) located in the Madison, WI. We specialize in the development and manufacturing of mammalian-expressed recombinant proteins, with a focus on monoclonal antibodies (mAbs). Our AI-based approach significantly shortens the timeline from lab research to clinical manufacturing, allowing for faster delivery of critical therapies to patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $1.2M
- Funding stage: Seed
- Last round: Seed (Jan 2025)
- Website: axiobiopharma.com
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Biopharma, Biotechnology, Life Science, Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/axio-biopharma-18910 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.